Literature DB >> 14203273

CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).

E H GRINNELL, T G SKILLMAN, R BARSE, C L MOLLER.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS; BLOOD SUGAR; CHEMISTRY; CHLORPROPAMIDE; CLINICAL RESEARCH; DIABETES MELLITUS; DRUG THERAPY; INSULIN; PHARMACOLOGY; TOLAZAMIDE; TOLBUTAMIDE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14203273

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

2.  Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes.

Authors:  J R Turtle
Journal:  Br Med J       Date:  1970-09-12

3.  A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.

Authors:  J A Moorhouse
Journal:  Can Med Assoc J       Date:  1967-03-04       Impact factor: 8.262

4.  Clinical experience with the oral antidiabetic compound, tolazamide.

Authors:  J B McKendry; K F Gfeller
Journal:  Can Med Assoc J       Date:  1967-03-04       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.